
If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.
Paxlovid (PF-07321332/ritonavir) does not have a Marketing Authorization. It has been granted an Emergency Use Authorization (EUA) by the Tunisia Ministry of Health for the treatment of COVID-19 in adults who do not require supplemental oxygen and who are at increased risk for progression to severe COVID-19.
PAXLOVID (PF-07321332/ritonavir)
If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.
PAXLOVID Quick Search
To report an adverse (event) reaction with Pfizer product, please contact Pfizer pharmacovigilance at [email protected].